Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 4
Submit an article Journal homepage
2,008
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma

Yongyu Yanga Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaView further author information
,
Lei Gaob Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaView further author information
,
Junzhang Chena Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaView further author information
,
Wang Xiaoa Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaView further author information
,
Ruoqi Liua Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaView further author information
&
Heping Kana Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5884-4746View further author information
ORCID Icon
Pages 9211-9231 | Received 02 Jan 2022, Accepted 21 Mar 2022, Published online: 18 Apr 2022

Related Research Data

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.